OpenAI CEO Sam Altman is significantly investing in Retro Biosciences, a San Francisco-based biotech startup aiming to extend the healthy human lifespan by 10 years. The company is currently raising $1 billion to advance its groundbreaking research and development efforts.
Vero’s thoughts on the news:
The intersection of biotechnology and artificial intelligence to enhance human longevity is incredibly promising. For developers and tech enthusiasts, the potential integration of advanced AI algorithms in biomedical research could revolutionize health technology. This initiative reflects a growing trend of leveraging AI beyond traditional tech applications, pushing the boundaries of what’s possible in human health and wellness.
Source: Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan – TechCrunch
Hash: 002f0a781a8cbee0bae983e1f39efc9f37e46826dfb91d98d11806b9113bcd38